Persistent parity-induced changes in growth factors, TGF-β3, and differentiation in the rodent mammary gland

Molecular Endocrinology

Volumn 16, Issue 9, 2002, Pages 2034-2051

  D'Cruz, Celina M ^a   Moody, Susan E ^a   Master, Stephen R ^a   Hartman, Jennifer L ^a   Keiper, Elizabeth A ^a   Imielinski, Marcin B ^a   Cox, James D ^a   Wang, James Y ^a   Ha, Seung I ^a   Keister, Blaine A ^a   Chodosh, Lewis A ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHIREGULIN; PLEIOTROPHIN; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA3;

ANAMNESIS; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CARCINOGENESIS; CANCER RISK; CELL STRUCTURE; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENITAL SYSTEM; HEMATOPOIETIC STEM CELL; IN SITU HYBRIDIZATION; MAMMARY GLAND; MOUSE; NONHUMAN; PARITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; RECEPTOR UPREGULATION; RISK ASSESSMENT;

ANIMALS; CELL DIFFERENTIATION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GROWTH SUBSTANCES; MAMMARY GLANDS, ANIMAL; MICE; MORPHOGENESIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PARITY; PREGNANCY; RATS; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA3;

ANIMALIA; RODENTIA;

EID: 6444245811     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2002-0073     Document Type: Article

References (79)

1. Age at first birth and breast cancer risk
2. Reproductive risk factors in a prospective study of breast cancer: The nurses' health study
3. Early age at first birth and decreased risk of breast cancer
4. The independent associations of parity, age at first full term pregnancy, and duration of breastfeeding with the risk of breast cancer
5. Characteristics that predict risk of breast cancer before and after the menopause
6. Combined effects of body size, parity, and menstrual events on breast cancer incidence in seven countries
7. A prospective study of reproductive factors and breast cancer. I. Parity
8. Pregnancy-related factors and risk of breast cancer in a prospective study of 29,981 Norwegian women
9. Developmental stage of the rat mammary gland as determinant of its susceptibility to 7,12-dimethylben(a)anthracene
10. Differentiation of the mammary gland and susceptibility to carcinogenesis
11. Refractoriness to mammary tumorigenesis in parous rats: Is it caused by persistent changes in the hormonal environment or permanent biochemical alterations in the mammary epithelia?
12. Refractoriness to mammary carcinogenesis in the parous mouse is reversible by hormonal stimulation induced by pituitary isografts
13. Parous rats regain high susceptibility to chemically induced mammary cancer after treatment with various mammotropic hormones
14. Hormonal prevention of breast cancer: Mimicking the protective effect of pregnancy
15. Hormones and mammary carcinogenesis in mice, rats, and humans: A unifying hypothesis
16. Pathogenesis of mammary carcinomas induced in rats by 7,12-dimethylbenz[a]anthracene
17. Relationship between previous reproductive history and chemically induced mammary cancer in rats
18. Influence of pregnancy and lactation on experimental mammary carcinogenesis
19. Critical significance of breast structure in the induction of mammary cancer in the rat
20. Rapid induction of mammary carcinoma in the rat and the influence of hormones on the tumors
21. Mammary cancer induced by a single feeding of polynuclear hydrocarbons and its suppression
22. Mammary carcinogenesis by 3-methylcholanthrene. II. Inhibitory effect of- pregnancy and lactation on tumor induction
23. Hormone-induced refractoriness to mammary carcinogenesis in Wistar-Furth rats
24. Protective effects of pregnancy and lactation against N-methyl-N-nitrosourea-induced mammary carcinomas in female Lewis rats
25. Chemical carcinogen-induced tumorigenesis in parous, involuted mouse mammary glands
26. Postnatal development of the rodent mammary gland
27. Comparative study of human and rat mammary tumorigenesis
28. Influence of age and parity on the development of the human breast
29. Development pattern of human breast and susceptibility to carcinogenesis
30. Prevention of mammary carcinogenesis in rats by pregnancy: Effect of full-term and interrupted pregnancy
31. Mammary gland development, reproductive history, and breast cancer risk
32. Persistent changes in gene expression induced by estrogen and progesterone in the rat mammary gland
33. Stimulation of adipose differentiation related protein (ADRP) expression in adipocyte precursors by long-chain fatty acids
34. Dynamic expression and activation of ERBB receptors in the developing mouse mammary gland
35. Differential expression of Id genes in multipotent myeloid progenitor cells: Id-1 is induced by early- and late-acting cytokines while Id-2 is selectively induced by cytokines that drive terminal granulocytic differentiation
36. Modulation of clusterin gene expression in the rat mammary gland during pregnancy, lactation, and involution
37. Transforming growth factor β regulates clusterin gene expression via modulation of transcription factor c-Fos
38. Apoptotic cell death and tissue remodeling during mouse mammary gland involution
39. Hoxa-9 represses transforming growth factor-β-induced osteopontin gene transcription
40. Transforming growth factor β3 induces cell death during the first stage of mammary gland involution
41. Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase
42. Molecular and cellular basis of genetic resistance to bacterial infection: The role of the early T-lymphocyte activation-1/osteopontin gene
43. Structure and function of lipopolysaccharide binding protein
44. Osteopontin: A protein with diverse functions
45. Leucocyte phenotypes in involuting and fully involuted mammary glandular tissues and secretions of sheep
46. Macrophage-derived metalloelastase is responsible for the generation of angiostatin in Lewis lung carcinoma
47. Eta-1 (osteopontin): An early component of type-1 (cell-mediated) immunity
48. Breast cancer (2)
49. Differential immunohistochemical detection of transforming growth factor α, amphiregulin and CRIPTO in human normal and malignant breast tissues
50. Expression of messenger RNA for amphiregulin, heregulin, and cripto-1, three new members of the epidermal growth factor family, in human breast carcinomas
51. Amphiregulin, epidermal growth factor receptor, and estrogen receptor expression in human primary breast cancer
52. Preneoplastic mammary tumor markers: Cripto and Amphiregulin are overexpressed in hyperplastic stages of tumor progression in transgenic mice
53. Amphiregulin as an autocrine growth factor for c-Ha-ras- and c-erbB-2-transformed human mammary epithelial cells
54. Antisense expression for amphiregulin suppresses tumorigenicity of a transformed human breast epithelial cell line
55. EGF-related peptides are involved in the proliferation and survival of MDA-MB-468 human breast carcinoma cells
56. Targeted inactivation of the EGF and amphiregulin genes reveals distinct roles for EGF receptor ligands in mouse mammary gland development
57. Pleiotrophin stimulates fibroblasts and endothelial and epithelial cells and is expressed in human cancer
58. Local control of mammary gland differentiation: Mammary-derived growth inhibitor and pleiotrophin
59. Pleiotrophin transforms NIH 3T3 cells and induces tumors in nude mice
60. Human breast cancer growth inhibited in vivo by a dominant negative pleiotrophin mutant
61. Type I IGF receptor in human breast diseases
62. Insulin-like growth factor-I (IGF-I) receptors in breast cancer
63. Endocrine effects of IGF-I on normal and transformed breast epithelial cells: Potential relevance to strategies for breast cancer treatment and prevention
64. Insulin-like growth factor binding protein-3 and insulin receptor substrate-1 in breast cancer: Correlation with clinical parameters and disease-free survival
65. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer
66. Biological and molecular bases of mammary carcinogenesis
67. Cellular basis of breast cancer susceptibility
68. p53 is a potential mediator of pregnancy and hormone-induced resistance to mammary carcinogenesis
69. TGF-β1-induced inhibition of mouse mammary ductal growth: Developmental specificity and characterization
70. Mammary tumor suppression by transforming growth factor β1 transgene expression
71. Dominant-negative interference of the transforming growth factor β type II receptor in mammary gland epithelium results in alveolar hyperplasia and differentiation in virgin mice
72. Transgenic mice overexpressing a dominant-negative type II tranforming growth factor receptor β receptor show enhanced tumorigenesis in the mammary gland and lung in reponse to the carcinogene 7,12-dimethylbenz-[a]-anthracene
73. Lactoferrin inhibits G1 cyclin-dependent kinases during growth arrest of human breast carcinoma cells
74. In vitro inhibition of mammary cell growth by lactoferrin: A comparative study
75. Human lactoferrin inhibits growth of solid tumors and development of experimental metastases in mice
76. Effects of human lactoferrin on NK cell cytotoxicity against haematopoietic and epithelial tumour cells
77. Modulation of natural killer and lymphokine-activated killer cell cytotoxicity by lactoferrin
78. The developmental pattern of Brca1 expression implies a role in differentiation of the breast and other tissues
79. Expression monitoring by hybridization to high-density oligonucleotide arrays